- Veri Yok
Türkçe
- English
- 简体中文
- 繁体中文
- Français
- Русский
- Italiano
- 日本語
- 한국어
- Português
- Deutsch
- Español
- Türkçe
- Ελληνικά
- Nederlands
- Tiếng Việt
- Polski
On August 8, local time, Jalisco, Mexico welcomed the grand opening of Yangtze Optics Mexico Cable S.A. de C.V., marking the eighth overseas production base of Yangtze Optical Fiber & Cable Co. ("Yangtze Fiber Optics") has successfully set up its eighth overseas production base in its 36-year development history, further advancing its internationalization strategy blueprint. Today, we are pr...
Recently, the Los Alamos National Laboratory (LANL) in the United States has developed a method for quantum light emitters, which stacks two different atomic thin materials together to achieve a light source that generates circularly polarized single photon streams. These light sources can also be used for various quantum information and communication applications.According to Han Htoon, a researc...
Recently, high-performance laser supplier Skylark Lasers announced that it has raised $5 million in investment to further advance its efforts in miniaturized laser technology.Skylark Lasers is established at the center of the Scottish Photonics Cluster, focusing on the design and production of compact diode pumped solid-state (C-DPSS) lasers with the purest spectral characteristics, providing high...
Alpes Laser was founded in 1998 in Nazhatel, Switzerland and was the first company to bring quantum cascade lasers to the market. It released its first continuous laser in 2001 and its first high gain laser in 2009, thus maintaining this priority position.In 2004, the first commercial laser was introduced.Principle: In a single mode laser, the grating is etched into the active region to force the ...
On July 3rd local time, Swiss ophthalmic care giant Alcon announced the acquisition of Israeli medical technology company Belkin Vision and its laser equipment assets for treating glaucoma.The transaction includes a prepayment of $81 million, of which approximately $65 million is in cash. In addition, if Alcon can establish this technology as the preferred first-line treatment option for clinical ...